维普期刊资源整合服务平台（V6.5）

88篇 您的检索式：作者名="Santantonio"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Chronic hepatitis B: Advances in treatment显示文摘Treatment of chronic hepatitis B(CHB) has markedly improved in the last 15 years due to the availability of direct antivirals which greatly increase therapeutic options. Currently, there are two classes of agents licensed for CHB treatment: standard or pegylated interferon alpha(IFN or Peg-IFN) and five nucleoside/nucleotide analogues(NAs). Long-term treatment with NAs is the treatment option most often used in the majority of CHB patients. Entecavir and tenofovir, the most potent NAs with high barrier to resistance, are recommended as first-line monotherapy by all major treatment guidelines and can lead to long-lasting viro-logical suppression, resulting in histological improve-ment or reversal of advanced fibrosis and reduction in disease progression and liver-related complications. In this review, we focus on current treatment strategies of chronic hepatitis B and discuss the most recent efficacy and safety data from clinical trials and real life clinical practice. Recent findings of response-guided approach-es are also discussed.	Teresa Antonia Santantonio Massimo Fasano	2014	World Journal of Hepatology2014，6，5：	12
2	Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment显示文摘	E. Sagnelli T. Santantonio N. Coppola M. Fasano M. Pisaturo C. Sagnelli	2014	Infection2014，，4：	2
3	Celiac Plexus Block: Injectate Spread and Pain Relief in Patients with Regional Anatomic Distortions显示文摘	Marcello De Cicco Mira Matovic Roberto Bortolussi Franco Coran Dario Fantin Fabio Fabiani Maria Caserta Cristina Santantonio Augusto Fracasso	2001	Anesthesiology2001，，4：	2
4	Long -tem follow-up of patients with anti Hbe/HBV DNA-positive chronic hepatitis B treated for 12months with lam ivudine显示文摘	Santantonio T Mazzola M Iacovazzi T	2000	Jhepatol2000，32，2：	1
5	Anti-Hbe-Positive Chronic hepatits B with HBVDNA in the serum response to a 6 month course of lymphoblastiold interforon 显示文摘	Pastore G Santantonio T Milella M	1992	J Hepatol1992，14，：	1
6	Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses显示文摘	Pollicino T Raffa G Santantonio T Gaeta GB Iannello G Alibrandi A		Journal of Virology0，，：	1
7	Estimating fine-root production and turnover from biomass and decomposition data:a compartment-flow model 显示文摘	Santantonio D Grace J C	1987	Canadian Journal of Forestry Research1987，17，：	1
8	Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum: responses to a 6-month course of lymphoblastoid interferon显示文摘	Pastore G Santantonio T Milella A	1992	J Hepatol1992，20，：	1
9	Neutralizing antibodies to recombinant alpha interferon and response to therapy in chronic hapatitis C rirus infection 显示文摘	Milella M Antonelli G Santantonio T	1993	Liver1993，13，：	1
10	Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy显示文摘	Jung MC Schneider R	1992	Virology1992，188，2：	1
11	Estimating fine-root production and turnover from biomass and decomposition data:a compartment-flow model显示文摘	SANTANTONIO D GRACE J C	1987	Can J For Res1987，17，：	1
12	Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepalitis B 显示文摘	Santantonio T Fasano M Durantel S	2009	Antivir Ther2009，14，4：	1
13	Hepatitis B virus genomes that cannot synthesize pre - S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy显示文摘	Santantonio T Jung MC Schneider R	1992	Virology1992，188，：	1
14	Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine显示文摘	Mazzola M Iacovazzi T	2000	J Hepatol2000，32，2：	1
15	显示文摘	Günther S von Breunig F Santantonio T	1999	J Hepatol1999，30，5：	1
16	Long-term follow-up of pationts with anti-hBel/HBv-DNA-positive chronic hepatitis B treated for 12 months with lamirudine显示文摘	SANTANTONIO T MAZZOLAM	2002	J hepatol2002，3，2：	1
17	Lamivudine is safe and effective in fulminant hepatitis B显示文摘	Santantonio T Mazzola M Pastore G	1999	J Hepatol1999，30，3：	1
18	HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5years显示文摘	Massimo Fasano Pietro Lampertico Alfredo Marzano Vito Di Marco Grazia Anna Niro Giuseppina Brancaccio Andrea Marengo Gaetano Scotto Maurizia Rossana Brunetto Giovanni Battista Gaeta Mario Rizzetto Gioacchino Angarano Teresa Santantonio	2012	Journal of Hepatology2012，，6：	1
19	HBV-DNA level in blood serum as a predictor of good response to therapy with interferon-alpha 2b of patients with chronic hepatitis B显示文摘	Simon K Rotter K Santantonio T	2000	Med Sci Monit2000，6，5：	1
20	Adefovir dipivoxil resistance patterns in patients with lamivudine - resistant chronic hepatitis B 显示文摘	Santantonio T Fasano M Durantel S	2009	Antivir Ther2009，14，4：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示